Lincoln Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 12-Sep-2025.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has fixed Friday, September 12, 2025 as the Record Date to determine shareholders eligible for the final dividend. The 31st Annual General Meeting is scheduled for September 30, 2025 via video conferencing. The company has proposed a final dividend of ₹1.80 per equity share (18% on face value of ₹10) for FY 2024-25, subject to shareholder approval at the AGM. The book closure period runs from September 13 to September 30, 2025. This is a routine corporate action announcement informing exchanges of key dates ahead of the AGM.
Shareholders holding shares as of the Record Date (September 12, 2025) will be eligible to receive the ₹1.80 per share dividend once approved at the AGM. This provides clarity for investors but the actual dividend yield depends on the current market price, which is not disclosed in this filing.